- Enrollment
- 100
- Started
- Jun 2020
- Completion
- Mar 2021
- Locations
- 1
- Countries
- 1
- Updated
- Jun 2020
Industry sponsor intelligence
Hamad Medical CorporationClinical Pipeline.
Lead-sponsor view of Hamad Medical Corporation's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 1
- Recruiting
- 0
- Active
- 0
- Completed
- 0
- Results posted
- 0
- Avg enrollment
- 100
Pipeline overview
Programs by phase and activity.
Velocity
Hamad Medical Corporation trials by start year
Study start year · indexed snapshot
Development
Trials by phase
1phase labels
Early Phase 10
Phase 10
Phase 20
Phase 30
Phase 41
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Bivalirudin → | 1 | 0 | 0 | 0 | 1 | 0 |
Active peptide trials
In motion now.
No studies in this snapshot.
Completed trials
Finished registry records.
No studies in this snapshot.
Search sponsor records
All Hamad Medical Corporation studies.
This page groups studies where Hamad Medical Corporation is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
1 matching study
Last registry update first
Recent updates